MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Eye movement"

  • 2018 International Congress

    Four eyelid and eye movement disorder cases misdiagnosed as seronegative ocular myasthenia gravis

    M. Kamada, K. Kume (Kita-gun, Japan)

    Objective: To report four eyelid and eye movement disorder cases misdiagnosed as seronegative ocular myasthenia gravis. Background: Myasthenia gravis (MG) is a disorder where neurotransmission…
  • 2018 International Congress

    Eye movement disorders after cerebellar infaction

    M. Munteanu (Bucharest, Romania)

    Objective: This study aims to demostrate that the posterior cerebellar vermis controls both saccade precision and smooth pursuit velocity in humans. Background: The posterior vermis…
  • 2018 International Congress

    Is chronic ocular motor dysfunction in syndrome of antiGAD antibody reversible with immune therapy?

    A. Mook, S. Gunzler, G. Wilmot, A. Shaikh (Cleveland, OH, USA)

    Objective: Is chronic ocular motor dysfunction in syndrome of antiGAD antibody reversible with immune therapy? Background: Increased serum titers of antiGAD antibody can be seen…
  • 2018 International Congress

    Oculomotor Behavior in Healthy Caribbean: Does it reflect an increased vulnerability to degenerative Parkinsonism?

    A. Lannuzel, A. Lackmy, B. Tressières, R. Edragas, V. Pélonde-Erimée, C. Bonnet, S. Rivaud-Péchoux, E. Roze, B. Gaymard (Pointe-à-Pitre, Guadeloupe)

    Objective: To investigate the impact of environmental factors on eye movement performances in two populations composed of carefully selected healthy subjects with strikingly different ethnic…
  • 2018 International Congress

    Update on Convergence Spasm: Review of Psychogenic and Organic Case Reports

    R. Fekete, S. Jankovic (Valhalla, NY, USA)

    Objective: The aim is to evaluate case reports and series of convergence spasm (CS). Background: CS consists of episodes of convergence of the eyes, miosis,…
  • 2018 International Congress

    Using saccades as an early test of levodopa treatment in Parkinson’s Disease

    Z.J. Lu, S. Dillon, P. Zetegren, M. Brzezick, C. Kennard, J. FitzGerald, C. (Oxford, United Kingdom)

    Objective: It is important to know what potential confounding effects the medications used to treat Parkinson’s disease (PD) have on eye movement, in order to…
  • 2017 International Congress

    Ocular Motor Disorders Among Filipino “LUBAG” or X-Linked Dystonia Parkinsonism (XDP) Patients

    M. Macas, E.C. Rossi, S. Abantas-Diamla, A. Punzalan-Sotelo, E. Palisoc, C. Go (Manila, Philippines)

    Objective: To determine the prevalence of ocular motor disorders among X-Linked Dystonia Parkinsonism (XDP) patients seen in Jose R Reyes Memorial Medical Center, and at…
  • 2017 International Congress

    Improvement of memory guided saccade amplitude by the STN DBS and target eccentricity

    A. YUGETA, Y. TERAO, Y. UGAWA (Tokyo, Japan)

    Objective: To investigate whether the subthalamic nucleus (STN) deep brain stimulation (DBS) improves the memory guided saccade (MGS) amplitude in the same degree in small…
  • 2017 International Congress

    UPDRS III score and RS latency can determine the possible neuromodulative role of STN DBS in Parkinson’s disease (PD) patients

    S. Szlufik, A. Przybyszewski, J. Dutkiewicz, P. Habela, T. Mandat, D. Koziorowski (Warsaw, Poland)

    Objective: The aim of this study was to evaluate the impact of STN DBS on the changes of UPDRS scale and RS parameters (OFF phase)…
  • 2017 International Congress

    Saccadic impairment in patients with Gaucher’s disease type 3

    J. Blume, C. Kämpe Björkvall, M. Machaczka, P. Svenningsson (Stockholm, Sweden)

    Objective: To characterize saccades in patients with chronic neuronopathic Gaucher’s disease (GD3) in relationship to their neurological and cognitive status using a computer-based eye-tracking technique.  Background: GD3 is…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley